They employed glial-fibrillary-acidic-protein (GFAP)-driven Cre glioblastoma mouse models, the allowing precise recombination of the activation of the KrasG12D oncogene and the homozygous deletion of the p53 tumor suppressor gene specifically within astrocyte lineage cells. The gene discussed is GFAP; the disease is glioblastoma.